Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

摘要

BackgroundBladder transitional cell carcinoma (BTCC) is the fourth most frequent neoplasia in men, clinically characterized by high recurrent rates and poor prognosis. Availability of urinary tumor biomarkers represents a convenient alternative for early detection and disease surveillance because of its direct contact with the tumor and sample accessibility.